Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system

Cancer Gene Therapy

Volumn 10, Issue 2, 2003, Pages 152-160

  Parada, Carlos ^a   Hernández Losa, Javier ^a   Guinea, Juan ^a   Sánchez Arévalo, Victor ^a   Fernández Soria, Victor ^a   Alvarez Vallina, Luis ^a   Sánchez Prieto, Ricardo ^a   Ramón y Cajal, Santiago ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Adenovirus E1a; Cisplatin; Gene therapy; Sensitivity; Thymidine kinase

Indexed keywords

CISPLATIN; GANCICLOVIR; HERPES SIMPLEX VIRUS THYMIDINE KINASE; RETROVIRUS VECTOR; THYMIDINE KINASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BYSTANDER EFFECT; CANCER CELL; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; GENE THERAPY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUICIDE GENE;

3T3 CELLS; ADENOVIRUS E1A PROTEINS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL CYCLE; CISPLATIN; CYCLIN B; DRUG SYNERGISM; GANCICLOVIR; GENE THERAPY; GENETIC ENGINEERING; HELA CELLS; HUMANS; MICE; RETROVIRIDAE; SIMPLEXVIRUS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; ANIMALIA; CUCUMBER MOSAIC VIRUS; MURINAE; SIMPLEXVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0037326135     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700550     Document Type: Article

References (30)

1. Springer CJ, Niculescu-Duvaz I. Prodrug-activating systems in suicide gene therapy. J Clin Invest. 2000;105:1161-1167.
2. Wildner O, Morris JC. Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses. J Gene Med. 2000;2:353-360.
3. Wildner O, Morris JC. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-TK: assessment of antitumor efficacy and toxicity. Cancer Res. 2000;60:4167-4174.
4. Alemany R, Balague C, Curiel D. Replicative adenoviruses for cancer therapy. Nat Biotechnol. 2000;7:723-727.
5. Heise C, Kirn DH. Replication-selective adenoviruses as oncolytic agents. J Clin Invest. 2000;7:847-851.
6. Bischoff JR, Kirn DH, Williams A, et al. An adenovirus mutant that replicates selectively in p53 deficient human tumor cells. Science. 1996;274:373-376.
7. Isley DD, Lee SH, Miller WH, Kuchta RD. Acyclic guanosine analogs inhibit DNA polymerases alpha, delta, and epsilon with very different potencies and have unique mechanisms of action. Biochemistr. 1995;34:2504-2510.
8. Miller WH, Miller RL. Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase. J Biol Chem. 1980;255:7204-7207.
9. Frank KB, Chiou JF, Cheng YC. Interaction of herpes simplex virus-induced DNA polymerase with 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate. J Biol Chem. 1984;259:1566-1569.
10. Halloran PJ, Fenton RG. Irreversible G2-M arrest and cytoskeletal reorganization induced by cytotoxic nucleoside analogues. Cancer Res. 1998;58:3855-3865.
11. Sarisky RT, Quail MR, Clark PE, et al. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir. J Virol. 2001;75:1761-1769.
12. Tomicic MT, Thust R, Sobol RW, Kaina B. DNA polymerase beta mediates protection of mammalian cells against ganciclovir-induced cytotoxicity and DNA breakage. Cancer Res. 2001;61:7399-7403.
13. Touraine RL, Vahanian N, Ramsey WJ, Blaese RM. Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions. Hum Gene Ther. 1998;9:2385-2391.
14. Mesnil M, Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res. 2000;60:3989-3999.
15. Carrio M, Mazo A, Lopez-Iglesias C, Estivill X, Fillat C. Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and connexin26 genes in pancreatic cells results in variable efficiency on the bystander killing: implications for gene therapy. Int J Cancer. 2001;94:81-88.
16. Aghi M, Kramm CM, Chou TC, Breakefield XO, Chiocca EA. Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies. J Natl Cancer Inst. 1998;90:370-380.
17. Wildner O, Blaese RM, Morris JC. Synergy between the herpes simplex virus TK/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan. Hum Gene Ther. 1999;10:2679-2687.
18. Lee YJ, Galoforo SS, Battle P, Lee H, Corry PM, Jessup JM. Replicating adenoviral vector-mediated transfer of a heatinducible double suicide gene for gene therapy. Cancer Gene Ther. 2001;6:397-404.
19. Barbeau D, Charbonneau R, Whalen SG, Bayley ST, Branton PE. Functional interactions within adenovirus E1a protein complexes. Oncogene. 1994;9:359-373.
20. Frisch MS, Mymryk JS. Adenovirus-5 E!A: paradox and paradigm. Nat Rev Mol Cell Biol. 2002;3:441-452.
21. Frisch SM. Tumor suppression activity of adenovirus E1a protein: anoikis and the epithelial phenotype. Adv Cancer Res. 2001;80:39-49.
22. Sánchez-Prieto R, Quintanilla M, Cano A, et al. Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus E1a gene. Oncogene. 1996;13:1083-1092.
23. Xing X, Yujiao Chang J, Hung M. Preclinical and clinical study of HER-2/neu-targeting cancer gene therapy. Adv Drug Deliv Rev. 1998;30:219-227.
24. Martin-Duque, et al. Adenovirus lacking 19-kDa and 55-kDa E1B genes exerts a marked cytotoxic effect in human malignant cells. Cancer Gene Ther. 1999;6:554-563.
25. Wei SJ, et al. S- and G2-phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase. Exp Cell Res. 1998;241:66-75.
26. Halloran PJ, Fenton RG. Irreversible G2-M arrest and cytoskeletal reorganization induced by cytotoxic nucleoside analogues. Cancer Res. 1998;58:3855-3865.
27. Beltinger C, Fulda S, Kammertoens T, Meyer E, Uckert W, Debatin KM. Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc Natl Acad Sci USA. 1999;96:8699-8704.
28. Yageta M, Tsunoda H, Yamanaka T, et al. The adenovirus E1a domains required for induction of DNA rereplication in G2/M arrested cells coincide with those required for apoptosis. Oncogene. 1999;18:4767-4776.
29. Wildner O, Blaese RM, Morris JC. Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase. Cancer Res. 1999;59:410-413.
30. Lambright ES, Amin K, Wiewrodt R, et al. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy. Gene Ther. 2001;12:946-953.